M1-derived extracellular vesicles enhance photodynamic therapy and promote immunological memory in preclinical models of colon cancer

Journal of Nanobiotechnology

Roman I. Koning¹  Ferry Ossendorp²  Martine J. Jager³  Ruben V. Huis in ‘t Veld⁴  Luis J. Cruz⁴  Pablo Lara⁴ 

[1] Department of Cell and Chemical Biology, Section Electron Microscopy, Leiden University Medical Centre (LUMC);Department of Immunology, Leiden University Medical Centre (LUMC);Department of Ophthalmology, Leiden University Medical Centre (LUMC);Department of Radiology, Leiden University Medical Centre (LUMC);

关键词: Photodynamic therapy;    Extracellular vesicles;    Exosomes;    Cancer;    Tumor microenvironment;    Immune modulation;   

DOI  :  10.1186/s12951-022-01448-z

来源: DOAJ

【 摘 要 】

Abstract Extracellular vesicles (EVs) are promising drug carriers of photosensitizers for photodynamic therapy (PDT) in cancer treatment, due to their ability to circulate in blood and enter cells efficiently. The therapeutic potential of EVs has been suggested to depend on the type and physiological state of their cell of origin. However, the effects of deriving EVs from various cells in different physiological states on their antitumor capacity are rarely evaluated. In the present study, we compared the antitumor efficacy of EV-mediated PDT by incorporating the photosensitizer Zinc Phthalocyanine (ZnPc) into EVs from multiple cells sources. ZnPc was incorporated by a direct incubation strategy into EVs derived from immune cells (M1-like macrophages and M2-like macrophages), cancer cells (B16F10 melanoma cancer cells) and external sources (milk). Our data show that all EVs are suitable carriers for ZnPc and enable efficient PDT in vitro in co-culture models and in vivo. We observed that EV-mediated PDT initiates immunogenic cell death through the release and exposure of damage associated molecular patterns (DAMPs) on cancer cells, which subsequently induced dendritic cell (DC) maturation. Importantly, of all ZnPc-EVs tested, in absence of light only M1-ZnPc displayed toxicity to MC38, but not to DC, in monoculture and in co-culture, indicating specificity for cancer over immune cells. In MC38 tumor-bearing mice, only M1-ZnPc induced a tumor growth delay compared to control in absence of light. Interestingly, M1- but not M2-mediated PDT, induced complete responses against MC38 tumors in murine models (100% versus 38% of cases, respectively), with survival of all animals up to at least 60 days post inoculation. Finally, we show that all cured animals are protected from a rechallenge with MC38 cells, suggesting the induction of immunological memory after EV-mediated PDT. Together, our data show the importance of the cell type from which the EVs are obtained and highlight the impact of the immunological state of these cells on the antitumor efficacy of EV-mediated PDT. Graphical Abstract

【 授权许可】

Unknown